Oncolytics Biotech
ONCY
#10283
Rank
A$72 M
Marketcap
A$0.53
Share price
-10.37%
Change (1 day)
-65.84%
Change (1 year)

Oncolytics Biotech (ONCY) - Total debt

Total debt on the balance sheet as of June 2026 : A$0.67 Million

According to Oncolytics Biotech 's latest financial reports the company's total debt is A$0.67 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Oncolytics Biotech - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$0.84 M-31.3%
2024-12-31A$1.22 M161.42%
2023-12-31A$0.46 M15.89%
2022-12-31A$0.4 M-43.01%
2021-12-31A$0.7 M72.81%
2020-12-31A$0.41 M-25.93%
2019-12-31A$0.55 M
2018-12-31N/A
2006-12-31A$0.16 M-7.51%
2005-12-31A$0.17 M9.47%
2004-12-31A$0.16 M3.61%
2003-12-31A$0.15 M-7.98%
2002-12-31A$0.16 M-8.4%
2001-12-31A$0.18 M3.19%
2000-12-31A$0.17 M13.52%
1999-12-31A$0.15 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
A$74.78 B 11,049,676.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$67.69 B 10,002,132.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
A$75.87 M 11,110.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
A$2.54 M 276.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$25.49 B 3,766,417.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
A$58.43 M 8,533.93%๐Ÿ‡บ๐Ÿ‡ธ USA